NFKB1 and colorectal cancer: In vitro studies have established that roburic acid can effectively suppress human colorectal cancer cell growth through inhibition of the NF-κB signaling pathway; however, whether roburic acid also exhibited antitumor activity in vivo through the same mechanism has not been clarified.